Marex (MRX) Cash & Equivalents (2022 - 2026)

Marex (MRX) has 4 years of Cash & Equivalents data on file, last reported at $2.9 billion in Q4 2025.

• In Q4 2025, Cash & Equivalents rose 12.7% year-over-year to $2.9 billion; the TTM figure through Dec 2025 stood at $2.9 billion (up 12.7% YoY), while the FY2025 annual figure was $2.9 billion, up 12.7% from the prior year.
• Cash & Equivalents improved to $2.9 billion in Q4 2025, from $2.6 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $2.9 billion in Q4 2025 and bottomed at $910.1 million in Q4 2022.
• A 4-year average of $2.0 billion and a median of $2.0 billion in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents jumped 72.34% — and 2025, when it grew 12.7%.
• Year by year, Cash & Equivalents stood at $910.1 million in 2022, then jumped by 63.0% to $1.5 billion in 2023, then jumped by 72.34% to $2.6 billion in 2024, then advanced by 12.7% to $2.9 billion in 2025.
• The last three Cash & Equivalents figures came in at $2.9 billion (Q4 2025), $2.6 billion (Q4 2024), and $1.5 billion (Q4 2023), per Business Quant data.

Peer Comparison